Indonesia mobilises cross-border efforts to combat malaria in Papua
Papua New Guinea accounts for 26.4 percent of all malaria cases in the Asia Pacific. - Antara via The Jakarta Post/ANN
JAKARTA: Amid the geographical and social complexities of Papua, new hope emerges through the formation of the Papua Malaria Consortium, a cross-sector strategic alliance born from the commitment of governors and the support of stakeholders to accelerate malaria elimination.
"If we want Indonesia to be malaria-free, Papua is the key," said Indonesian Minister of Health Budi Gunadi Sadikin during a press conference on Tuesday (June 17), held on the sidelines of the 9th Asia Pacific Leaders' Summit on Malaria Elimination in Bali, which brought together over 250 participants from 23 countries and regions and international organisations.
He and Deputy Minister of Home Affairs Ribka Haluk led a meeting with six governors from across Papua to develop a more targeted, cross-sector strategy.
Papua, the easternmost region of Indonesia, accounts for over 93 per cent of the country's total malaria cases and has now become the epicentre of Indonesia's fight to eliminate the disease.
According to Budi, elimination in Papua is not only a health target but also a step toward achieving social justice and strengthening an inclusive health system.
Sarthak Das, chief executive officer of the Asia Pacific Leaders Malaria Alliance, expressed support for Indonesia's move to prioritise Papua in malaria elimination efforts. "Strong local leadership and cross-country collaboration are key to achieving the Asia Pacific region's malaria-free target by 2030," he said.
This local commitment is also reinforced by the Bilateral Joint Action Plan signed between Indonesia and Papua New Guinea on Monday. The cross-border cooperation framework aims to ensure that malaria control efforts are carried out in an integrated and equitable manner in areas that are geographically and epidemiologically interconnected.
Papua New Guinea accounts for 26.4 percent of all malaria cases in the Asia Pacific. Therefore, Das added, Indonesia's ability to gain control in Papua would be a vital signal that similar success is possible in Papua New Guinea.
The Global Fund, one of the key funding partners, affirmed its commitment to supporting Indonesia's efforts focused on malaria elimination in Papua.
"I acknowledge the significant progress made by Indonesia in its fight against malaria, and the Global Fund is fully committed to supporting its partners in the region to combat and eliminate malaria across the Asia Pacific," said Peter Sands, executive director of the Global Fund.
Sands also welcomed the launch of "Indonesia's Call to End Malaria" at the high-level forum, a national initiative to push for comprehensive malaria elimination.
Indonesia's efforts go beyond commitment. The government is expanding the distribution of bed nets, strengthening surveillance systems, increasing the number and capacity of local health workers, and implementing community-based approaches that respect local Papuan wisdom, alongside treatment and vaccine development.
Although challenges remain, especially in terms of geographical access, climate change, and population mobility, these joint efforts show that malaria elimination is no longer a distant dream. With strong political will, international support, and data-driven strategies, Papua could become an inspiring malaria elimination success story for the region. - Xinhua
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
7 hours ago
- The Star
Indonesia mobilises cross-border efforts to combat malaria in Papua
Papua New Guinea accounts for 26.4 percent of all malaria cases in the Asia Pacific. - Antara via The Jakarta Post/ANN JAKARTA: Amid the geographical and social complexities of Papua, new hope emerges through the formation of the Papua Malaria Consortium, a cross-sector strategic alliance born from the commitment of governors and the support of stakeholders to accelerate malaria elimination. "If we want Indonesia to be malaria-free, Papua is the key," said Indonesian Minister of Health Budi Gunadi Sadikin during a press conference on Tuesday (June 17), held on the sidelines of the 9th Asia Pacific Leaders' Summit on Malaria Elimination in Bali, which brought together over 250 participants from 23 countries and regions and international organisations. He and Deputy Minister of Home Affairs Ribka Haluk led a meeting with six governors from across Papua to develop a more targeted, cross-sector strategy. Papua, the easternmost region of Indonesia, accounts for over 93 per cent of the country's total malaria cases and has now become the epicentre of Indonesia's fight to eliminate the disease. According to Budi, elimination in Papua is not only a health target but also a step toward achieving social justice and strengthening an inclusive health system. Sarthak Das, chief executive officer of the Asia Pacific Leaders Malaria Alliance, expressed support for Indonesia's move to prioritise Papua in malaria elimination efforts. "Strong local leadership and cross-country collaboration are key to achieving the Asia Pacific region's malaria-free target by 2030," he said. This local commitment is also reinforced by the Bilateral Joint Action Plan signed between Indonesia and Papua New Guinea on Monday. The cross-border cooperation framework aims to ensure that malaria control efforts are carried out in an integrated and equitable manner in areas that are geographically and epidemiologically interconnected. Papua New Guinea accounts for 26.4 percent of all malaria cases in the Asia Pacific. Therefore, Das added, Indonesia's ability to gain control in Papua would be a vital signal that similar success is possible in Papua New Guinea. The Global Fund, one of the key funding partners, affirmed its commitment to supporting Indonesia's efforts focused on malaria elimination in Papua. "I acknowledge the significant progress made by Indonesia in its fight against malaria, and the Global Fund is fully committed to supporting its partners in the region to combat and eliminate malaria across the Asia Pacific," said Peter Sands, executive director of the Global Fund. Sands also welcomed the launch of "Indonesia's Call to End Malaria" at the high-level forum, a national initiative to push for comprehensive malaria elimination. Indonesia's efforts go beyond commitment. The government is expanding the distribution of bed nets, strengthening surveillance systems, increasing the number and capacity of local health workers, and implementing community-based approaches that respect local Papuan wisdom, alongside treatment and vaccine development. Although challenges remain, especially in terms of geographical access, climate change, and population mobility, these joint efforts show that malaria elimination is no longer a distant dream. With strong political will, international support, and data-driven strategies, Papua could become an inspiring malaria elimination success story for the region. - Xinhua
The Star
10-06-2025
- The Star
Vietnam exports first African swine fever vaccine batch to Indonesia
Workers at AVAC Vietnam preparing a shipment of African swine fever vaccine for export to Indonesia. — Courtesy of AVAC HANOI: Biotechnology firm AVAC Vietnam Joint Stock Company has exported its first shipment of African swine fever (ASF) vaccines to Indonesia, a major milestone in the country's efforts to bring domestically developed veterinary vaccines to the international market. The shipment, consisting of 120,000 doses of the AVAC ASF LIVE vaccine, was sent to Indonesia on Monday following nearly three years of evaluation and testing in collaboration with Indonesian authorities. The vaccine was officially approved for use by Indonesia's Ministry of Agriculture in April this year. The importer and distributor is PT. Biotis Prima Agrisindo, based in West Java. According to Nguyen Van Diep, General Director of AVAC Vietnam, the export underscores the vaccine's quality and efficacy, having passed Indonesia's stringent veterinary approval process. He said the milestone reflected not only the company's success but also the progress of Vietnam's veterinary vaccine sector in establishing a presence on the global stage. The live attenuated vaccine is the first of its kind in the world to have been successfully developed and commercialised, a result of intensive research by AVAC. The product has so far been used to administer over 3.5 million doses, with around three million doses deployed across Vietnam to help contain ASF outbreaks in various localities. Nearly 500,000 doses have already been exported to the Philippines and Nigeria, both of which have responded positively to the vaccine. AVAC currently maintains a reserve of approximately 1.5 million doses to meet urgent domestic and international demand. The company is also pursuing regulatory approval in several other countries, including India, Malaysia, Nepal and Myanmar. In Vietnam, the vaccine has been rolled out on a large scale in provinces such as Cao Bang, Lang Son, Bac Ninh, Hai Duong, Hai Phong, Quang Ninh, Quang Ngai and Tra Vinh, with the support of local funding. Field results have shown the vaccine to be highly effective and safe, with no recurrence of ASF in vaccinated herds. Veterinary authorities are continuing to assess the vaccine's use in breeding pigs, including both sows and boars, to extend protection across the entire pig population. Initial trials have indicated good safety and efficacy, though full evaluation is still underway. Le Toan Thang, head of Veterinary Medicine Management Division at the Department of Livestock Production and Animal Health, said the successful export to Indonesia further demonstrated the effectiveness of Vietnamese-made vaccines. He said that Vietnam's ability to control ASF domestically helped build trust in the product and opened the door for more exports. All exported veterinary vaccines must undergo rigorous testing, independent trials and safety assessments in the importing country before they are approved for use. AVAC's product has successfully met these standards. AVAC is one of three domestic manufacturers currently licensed to produce ASF vaccines in Vietnam, alongside Navetco Central Veterinary Medicine JSC and Dabaco Group. — Vietnam News/ANN
Barnama
05-06-2025
- Barnama
Indonesia Banks On Tech In US$240 Bln Healthcare Overhaul
By Mohd Iswandi Kasan Anuar JAKARTA, June 5 (Bernama) -- Indonesia expects its healthcare spending to hit US$240 billion over the next five years, with approximately one-third allocated to procuring medical equipment and developing health technology. Health Minister Budi Gunadi Sadikin said Indonesia would need an additional US$84 billion over five years - about three times its current healthcare budget - to match healthcare service standards comparable to neighbouring Malaysia. bootstrap slideshow 'This is the right time to act. Let us build a resilient and modern Indonesian healthcare system together,' he said in a statement on Thursday, emphasising the need for technology-driven solutions to ensure the system remains robust and responsive. The Health Ministry said Indonesia is undergoing a critical healthcare transformation, with medical technology such as the PCSK9 inhibitor - a next-generation cholesterol-lowering injection - playing a key role in building a resilient and sustainable system amid fiscal constraints. Budi Gunadi said the drug would be rolled out to 500 hospitals nationwide, providing a more efficient alternative to traditional therapies that require daily administration. "The PCSK9 drug is a game-changer, and just one example of the many medical innovations we can adopt,' he said. -- BERNAMA
